MedTrace Logo

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

NCT03371862 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2020-08-14

No results posted yet for this study

Summary

Pilot study looking at the effect on Liraglutide in the reduction of parenteral support in patients with short bowel.

Conditions

  • Short Bowel Syndrome

Interventions

DRUG

Liraglutide Pen Injector [Victoza]

Pilot study of liraglutide in patients with short bowel.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Siddhartha Oke · Imperial College London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2020-08-06
Completion
2020-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371862 on ClinicalTrials.gov